UK markets closed

NIKKEI 225
38,356.06
+176.60(+0.46%)
HANG SENG
19,073.71
-41.35(-0.22%)
CRUDE OIL
77.92
-1.20(-1.52%)
GOLD FUTURES
2,361.90
+18.90(+0.81%)
DOW
39,414.21
-17.30(-0.04%)
Bitcoin GBP
48,667.39
-1,213.82(-2.43%)

What is the Lifetime ISA? How the retirement income option could help you

The lifetime ISA has real benefits for groups such as the self-employed

GILD Jan 2026 80.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.1000

0.0000

(0.00%)

As of 02:50PM EDT. Market open.

Business Wire
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo Finance
One stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Zacks
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.